Epigenetic mechanisms in epilepsy

Progress in Brain Research

Volumn 213, Issue C, 2014, Pages 279-316

  Kobow, Katja ^a   Blümcke, Ingmar ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Chromatin remodeling; DNA methylation; Epileptic encephalopathy; Gene regulation; Genetic epilepsy; Hippocampus; Histone code; Metabolism; Noncoding RNA; Temporal lobe epilepsy

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTISENSE OLIGONUCLEOTIDE; DNA; LONG UNTRANSLATED RNA;

ARTICLE; BRAIN DISEASE; BRAIN FUNCTION; BRAIN MATURATION; BRAIN METABOLISM; CELLS BY BODY ANATOMY; CHROMATIN STRUCTURE; CHROMOSOME PAIRING; DNA METHYLATION; EPIGENETICS; GENE SILENCING; GENERALIZED EPILEPSY; GENOME; HISTONE MODIFICATION; HUMAN; INFORMATION STORAGE; INFORMATION SYSTEM; NERVE CELL DIFFERENTIATION; PHENOTYPIC VARIATION; PRIORITY JOURNAL; STIMULUS RESPONSE; ANIMAL; EPILEPSY; GENETIC EPIGENESIS; GENETICS;

ANIMALS; EPIGENESIS, GENETIC; EPILEPSY; HUMANS;

EID: 84924987118     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63326-2.00014-4     Document Type: Chapter

References (209)

1. Amir R.E., Van Den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23:185-188.
2. Aronica E., Fluiter K., Iyer A., Zurolo E., Vreijling J., Van Vliet E.A., Baayen J.C., Gorter J.A. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 2010, 31:1100-1107.
3. Baldelli E., Leo G., Andreoli N., Fuxe K., Biagini G., Agnati L.F. Homocysteine potentiates seizures and cell loss induced by pilocarpine treatment. Neuromol. Med. 2010, 12:248-259.
4. Barres R., Osler M.E., Yan J., Rune A., Fritz T., Caidahl K., Krook A., Zierath J.R. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 2009, 10:189-198.
5. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
6. Baujat G., Cormier-Daire V. Sotos syndrome. Orphanet J. Rare Dis. 2007, 2:36.
7. Becker A.J., Chen J., Zien A., Sochivko D., Normann S., Schramm J., Elger C.E., Wiestler O.D., Blumcke I. Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 2003, 18:2792-2802.
8. Belhedi N., Perroud N., Karege F., Vessaz M., Malafosse A., Salzmann A. Increased CPA6 promoter methylation in focal epilepsy and in febrile seizures. Epilepsy Res. 2014, 108:144-148.
9. Bergman Y., Cedar H. DNA methylation dynamics in health and disease. Nat. Struct. Mol. Biol. 2013, 20:274-281.
10. Berkovic S.F., Scheffer I.E. Genetics of the epilepsies. Epilepsia 2001, 42(Suppl. 5):16-23.
11. Bernstein B.E., Humphrey E.L., Erlich R.L., Schneider R., Bouman P., Liu J.S., Kouzarides T., Schreiber S.L. Methylation of histone H3 Lys 4 in coding regions of active genes. Proc. Natl. Acad. Sci. 2002, 99:8695-8700.
12. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., Feil R., Schreiber S.L., Lander E.S. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
13. Bestor T.H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 2000, 9:2395-2402.
14. Bienvenu T., Chelly J. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat. Rev. Genet. 2006, 7:415-426.
15. Bienvenu T., Poirier K., Friocourt G., Bahi N., Beaumont D., Fauchereau F., Benjeema L., Zemni R., Vinet M.-C., Francis F., Couvert P., Gomot M., Moraine C., Van Bokhoven H., Kalscheuer V., Frints S., Gecz J., Ohzaki K., Chaabouni H., Fryns J.-P., Desportes V., Beldjord C., Chelly J. ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum. Mol. Genet. 2002, 11:981-991.
16. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16:6-21.
17. Boison D. The adenosine kinase hypothesis of epileptogenesis. Prog. Neurobiol. 2008, 84:249-262.
18. Boison D., Sandau U.S., Ruskin D.N., Kawamura M., Masino S.A. Homeostatic control of brain function-new approaches to understand epileptogenesis. Front. Cell. Neurosci. 2013, 7:109.
19. Brinkman A.B., Gu H., Bartels S.J., Zhang Y., Matarese F., Simmer F., Marks H., Bock C., Gnirke A., Meissner A., Stunnenberg H.G. Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk. Genome Res. 2012, 22:1128-1138.
20. Brueckner B., Garciaboy R., Siedlecki P., Musch T., Kliem H.C., Zielenkiewicz P., Suhai S., Wiessler M., Lyko F. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res. 2005, 65:6305-6311.
21. Cao X., Yeo G., Muotri A.R., Kuwabara T., Gage F.H. Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci. 2006, 29:77-103.
22. Carvill G.L., Heavin S.B., Yendle S.C., Mcmahon J.M., O'Roak B.J., Cook J., Khan A., Dorschner M.O., Weaver M., Calvert S., Malone S., Wallace G., Stanley T., Bye A.M., Bleasel A., Howell K.B., Kivity S., MacKay M.T., Rodriguez-Casero V., Webster R., Korczyn A., Afawi Z., Zelnick N., Lerman-Sagie T., Lev D., Moller R.S., Gill D., Andrade D.M., Freeman J.L., Sadleir L.G., Shendure J., Berkovic S.F., Scheffer I.E., Mefford H.C. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat. Genet. 2013, 45:825-830.
23. Cascella B., Mirica L.M. Kinetic analysis of iron-dependent histone demethylases: α-ketoglutarate substrate inhibition and potential relevance to the regulation of histone demethylation in cancer cells. Biochemistry 2012, 51:8699-8701.
24. Chen Z., Karaplis A.C., Ackerman S.L., Pogribny I.P., Melnyk S., Lussier-Cacan S., Chen M.F., Pai A., John S.W., Smith R.S., Bottiglieri T., Bagley P., Selhub J., Rudnicki M.A., James S.J., Rozen R. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 2001, 10:433-443.
25. Chia N., Wang L., Lu X., Senut M.C., Brenner C., Ruden D.M. Hypothesis: environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics 2011, 6:853-856.
26. Chouliaras L., Mastroeni D., Delvaux E., Grover A., Kenis G., Hof P.R., Steinbusch H.W., Coleman P.D., Rutten B.P., Van Den Hove D.L. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol. Aging 2013, 34:2091-2099.
27. Clark S.J., Harrison J., Frommer M. CpNpG methylation in mammalian cells. Nat. Genet. 1995, 10:20-27.
28. Das N.D., Chai Y.G. Neuroinflammation on the epigenetics of neural stem cells. Neural Stem Cells-New Perspectives 2013, InTech Europe, Rijeka, Croatia. D.L. Bonfanti (Ed.).
29. Das N.D., Choi M.R., et al. Functional analysis of histone demethylase Jmjd2b on lipopolysaccharide-treated murine neural stem cells (NSCs). Neurotox. Res. 2013, 23(2):154-165.
30. Davis T.H., Cuellar T.L., Koch S.M., Barker A.J., Harfe B.D., McManus M.T., Ullian E.M. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 2008, 28:4322-4330.
31. De La Serna I.L., Ohkawa Y., Imbalzano A.N. Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat. Rev. Genet. 2006, 7:461-473.
32. De Napoles M., Mermoud J.E., Wakao R., Tang Y.A., Endoh M., Appanah R., Nesterova T.B., Silva J., Otte A.P., Vidal M., Koseki H., Brockdorff N. Polycomb group proteins ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Dev. Cell 2004, 7:663-676.
33. De Pietri Tonelli D., Pulvers J.N., Haffner C., Murchison E.P., Hannon G.J., Huttner W.B. miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development 2008, 135:3911-3921.
34. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011, 25:1010-1022.
35. Di Lorenzo A., Bedford M.T. Histone arginine methylation. FEBS Lett. 2011, 585:2024-2031.
36. Dulac C. Brain function and chromatin plasticity. Nature 2010, 465:728-735.
37. Edwards C.A., Ferguson-Smith A.C. Mechanisms regulating imprinted genes in clusters. Curr. Opin. Cell Biol. 2007, 19:281-289.
38. Edwards J.R., O'Donnell A.H., Rollins R.A., Peckham H.E., Lee C., Milekic M.H., Chanrion B., Fu Y., Su T., Hibshoosh H., Gingrich J.A., Haghighi F., Nutter R., Bestor T.H. Chromatin and sequence features that define the fine and gross structure of genomic methylation patterns. Genome Res. 2010, 20:972-980.
39. Eglen R.M., Reisine T. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview. J. Biomol. Screen. 2011, 16:1137-1152.
40. Elliott R.C., Miles M.F., Lowenstein D.H. Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth. J. Neurosci. 2003, 23:2218-2227.
41. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
42. Evans J.C., Archer H.L., Colley J.P., Ravn K., Nielsen J.B., Kerr A., Williams E., Christodoulou J., Gecz J., Jardine P.E., Wright M.J., Pilz D.T., Lazarou L., Cooper D.N., Sampson J.R., Butler R., Whatley S.D., Clarke A.J. Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur. J. Hum. Genet. 2005, 13:1113-1120.
43. Fasano C.A., Phoenix T.N., Kokovay E., Lowry N., Elkabetz Y., Dimos J.T., Lemischka I.R., Studer L., Temple S. Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain. Genes Dev. 2009, 23:561-574.
44. Fatica A., Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. Genet. 2014, 15:7-21.
45. Feng J., Fouse S., Fan G. Epigenetic regulation of neural gene expression and neuronal function. Pediatr. Res. 2007, 61:58R-63R.
46. Feng J., Zhou Y., Campbell S.L., Le T., Li E., Sweatt J.D., Silva A.J., Fan G. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 2010, 13:423-430.
47. Fischer A., Sananbenesi F., Wang X., Dobbin M., Tsai L.H. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007, 447:178-182.
48. Fischle W. Talk is cheap-cross-talk in establishment, maintenance, and readout of chromatin modifications. Genes Dev. 2008, 22:3375-3382.
49. Fournier A., Sasai N., Nakao M., Defossez P.A. The role of methyl-binding proteins in chromatin organization and epigenome maintenance. Brief. Funct. Genomics 2012, 11:251-264.
50. Garriga-Canut M., Schoenike B., Qazi R., Bergendahl K., Daley T.J., Pfender R.M., Morrison J.F., Ockuly J., Stafstrom C., Sutula T., Roopra A. 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 2006, 9:1382-1387.
51. Gibbons R. Alpha thalassaemia-mental retardation, X linked. Orphanet J. Rare Dis. 2006, 1:15.
52. Goll M.G., Bestor T.H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 2005, 74:481-514.
53. Gong Z., Zhu J.K. Active DNA demethylation by oxidation and repair. Cell Res. 2011, 21:1649-1651.
54. Gorter J.A., Van Vliet E.A., Aronica E., Breit T., Rauwerda H., Lopes Da Silva F.H., Wadman W.J. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J. Neurosci. 2006, 26:11083-11110.
55. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., Sleeman J.P., Lo Coco F., Nervi C., Pelicci P.G., Heinzel T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. Embo J. 2001, 20:6969-6978.
56. Gouder N., Scheurer L., Fritschy J.M., Boison D. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J. Neurosci. 2004, 24:692-701.
57. Gowher H., Jeltsch A. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG [correction of non-CpA] sites. J. Mol. Biol. 2001, 309:1201-1208.
58. Goyette P., Frosst P., Rosenblatt D.S., Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am. J. Hum. Genet. 1995, 56:1052-1059.
59. Graff J., Tsai L.H. Histone acetylation: molecular mnemonics on the chromatin. Nat. Rev. Neurosci. 2013, 14:97-111.
60. Grandjean V., Yaman R., Cuzin F., Rassoulzadegan M. Inheritance of an epigenetic mark: the CpG DNA methyltransferase 1 is required for de novo establishment of a complex pattern of non-CpG methylation. PLoS One 2007, 2:e1136.
61. Guerrini R., Shanahan J.L., Carrozzo R., Bonanni P., Higgs D.R., Gibbons R.J. A nonsense mutation of the ATRX gene causing mild mental retardation and epilepsy. Ann. Neurol. 2000, 47:117-121.
62. Guo J.U., Ma D.K., Mo H., Ball M.P., Jang M.H., Bonaguidi M.A., Balazer J.A., Eaves H.L., Xie B., Ford E., Zhang K., Ming G.L., Gao Y., Song H. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat. Neurosci. 2011, 14:1345-1351.
63. Gupta S., Kim S.Y., Artis S., Molfese D.L., Schumacher A., Sweatt J.D., Paylor R.E., Lubin F.D. Histone methylation regulates memory formation. J. Neurosci. 2010, 30:3589-3599.
64. Gupta-Agarwal S., Franklin A.V., Deramus T., Wheelock M., Davis R.L., Mcmahon L.L., Lubin F.D. G9a/GLP histone lysine dimethyltransferase complex activity in the hippocampus and the entorhinal cortex is required for gene activation and silencing during memory consolidation. J. Neurosci. 2012, 32:5440-5453.
65. Hahn M.A., Qiu R., Wu X., Li A.X., Zhang H., Wang J., Jui J., Jin S.G., Jiang Y., Pfeifer G.P., Lu Q. Dynamics of 5-hydroxymethylcytosine and chromatin marks in mammalian neurogenesis. Cell Rep. 2013, 3:291-300.
66. Hahnen E., Hauke J., Trankle C., Eyupoglu I.Y., Wirth B., Blumcke I. Histone deacetylase inhibitors: possible implications for neurodegenerative disorders. Expert Opin. Investig. Drugs. 2008, 17:169-184.
67. Harden C.L., Meador K.J., Pennell P.B., Hauser W.A., Gronseth G.S., French J.A., Wiebe S., Thurman D., Koppel B.S., Kaplan P.W., Robinson J.N., Hopp J., Ting T.Y., Gidal B., Hovinga C.A., Wilner A.N., Vazquez B., Holmes L., Krumholz A., Finnell R., Hirtz D., Le Guen C. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009, 50:1237-1246.
68. Hatzimichael E., Crook T. Cancer epigenetics: new therapies and new challenges. J Drug Deliv 2013, 2013:529312.
69. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5:522-531.
70. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., Barrera L.O., Van Calcar S., Qu C., Ching K.A., Wang W., Weng Z., Green R.D., Crawford G.E., Ren B. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39:311-318.
71. Helbig I., Lowenstein D.H. Genetics of the epilepsies: where are we and where are we going?. Curr. Opin. Neurol. 2013, 26:179-185.
72. Hendriksen H., Datson N.A., Ghijsen W.E., Van Vliet E.A., Da Silva F.H., Gorter J.A., Vreugdenhil E. Altered hippocampal gene expression prior to the onset of spontaneous seizures in the rat post-status epilepticus model. Eur. J. Neurosci. 2001, 14:1475-1484.
73. Hengst U., Cox L.J., Macosko E.Z., Jaffrey S.R. Functional and selective RNA interference in developing axons and growth cones. J. Neurosci. 2006, 26:5727-5732.
74. Henshall D.C. MicroRNAs in the pathophysiology and treatment of status epilepticus. Front. Mol. Neurosci. 2013, 6:37.
75. Hirose S., Mohney R.P., Okada M., Kaneko S., Mitsudome A. The genetics of febrile seizures and related epilepsy syndromes. Brain Dev. 2003, 25:304-312.
76. Hitchler M.J., Domann F.E. Redox regulation of the epigenetic landscape in cancer: a role for metabolic reprogramming in remodeling the epigenome. Free Radic. Biol. Med. 2012, 53:2178-2187.
77. Hojfeldt J.W., Agger K., Helin K. Histone lysine demethylases as targets for anticancer therapy. Nat. Rev. Drug Discov. 2013, 12:917-930.
78. Hu X.L., Cheng X., Cai L., Tan G.H., Xu L., Feng X.Y., Lu T.J., Xiong H., Fei J., Xiong Z.Q. Conditional deletion of NRSF in forebrain neurons accelerates epileptogenesis in the kindling model. Cereb. Cortex. 2011, 21(9):2158-2165.
79. Huang Y., Myers S.J., Dingledine R. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. Nat. Neurosci. 1999, 2:867-872.
80. Huang Y., Doherty J.J., Dingledine R. Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J. Neurosci. 2002, 22:8422-8428.
81. Huidobro C., Fernandez A.F., Fraga M.F. The role of genetics in the establishment and maintenance of the epigenome. Cell. Mol. Life Sci. 2013, 70(9):1543-1573.
82. Hutnick L.K., Golshani P., Namihira M., Xue Z., Matynia A., Yang X.W., Silva A.J., Schweizer F.E., Fan G. DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation. Hum. Mol. Genet. 2009, 18:2875-2888.
83. Ichiyanagi T., Ichiyanagi K., Miyake M., Sasaki H. Accumulation and loss of asymmetric non-CpG methylation during male germ-cell development. Nucleic Acids Res. 2013, 41:738-745.
84. Iwase S., Lan F., Bayliss P., De La Torre-Ubieta L., Huarte M., Qi H.H., Whetstine Johnathan R., Bonni A., Roberts T.M., Shi Y. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 2007, 128:1077-1088.
85. Jensen L.R., Amende M., Gurok U., Moser B., Gimmel V., Tzschach A., Janecke A.R., Tariverdian G., Chelly J., Fryns J.-P., Van Esch H., Kleefstra T., Hamel B., Moraine C., Gécz J., Turner G., Reinhardt R., Kalscheuer V.M., Ropers H.-H., Lenzner S. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 2005, 76:227-236.
86. Jia Y.H., Zhu X., Li S.Y., Ni J.H., Jia H.T. Kainate exposure suppresses activation of GluR2 subunit promoter in primary cultured cerebral cortical neurons through induction of RE1-silencing transcription factor. Neurosci. Lett. 2006, 403:103-108.
87. Jian L., Nagarajan L., De Klerk N., Ravine D., Bower C., Anderson A., Williamson S., Christodoulou J., Leonard H. Predictors of seizure onset in Rett syndrome. J. Pediatr. 2006, 149:542-547. e3.
88. Jimenez-Mateos E.M., Engel T., Merino-Serrais P., Mckiernan R.C., Tanaka K., Mouri G., Sano T., O'Tuathaigh C., Waddington J.L., Prenter S., Delanty N., Farrell M.A., O'Brien D.F., Conroy R.M., Stallings R.L., Defelipe J., Henshall D.C. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat. Med. 2012, 18:1087-1094.
89. Jobe E.M., Mcquate A.L., Zhao X. Crosstalk among epigenetic pathways regulates neurogenesis. Front. Neurosci. 2012, 6:59.
90. Jørgensen S., Schotta G., Sørensen C.S. Histone H4 Lysine 20 methylation: key player in epigenetic regulation of genomic integrity. Nucleic Acids Res. 2013, 41:2797-2806.
91. Jovicic A., Roshan R., Moisoi N., Pradervand S., Moser R., Pillai B., Luthi-Carter R. Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J. Neurosci. 2013, 33:5127-5137.
92. Kawase-Koga Y., Otaegi G., Sun T. Different timings of Dicer deletion affect neurogenesis and gliogenesis in the developing mouse central nervous system. Dev. Dyn. 2009, 238:2800-2812.
93. Kazantsev A.G., Thompson L.M. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat. Rev. Drug Discov. 2008, 7:854-868.
94. Kelly T.K., De Carvalho D.D., Jones P.A. Epigenetic modifications as therapeutic targets. Nat. Biotechnol. 2010, 28:1069-1078.
95. Kerimoglu C., Agis-Balboa R.C., Kranz A., Stilling R., Bahari-Javan S., Benito-Garagorri E., Halder R., Burkhardt S., Stewart A.F., Fischer A. Histone-methyltransferase MLL2 (KMT2B) is required for memory formation in mice. J. Neurosci. 2013, 33:3452-3464.
96. Khalil A.M., Faghihi M.A., Modarresi F., Brothers S.P., Wahlestedt C. A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One 2008, 3:e1486.
97. Khalil A.M., Guttman M., Huarte M., Garber M., Raj A., Rivea Morales D., Thomas K., Presser A., Bernstein B.E., Van Oudenaarden A., Regev A., Lander E.S., Rinn J.L. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. 2009, 106:11667-11672.
98. Khan S.N., Khan A.U. Role of histone acetylation in cell physiology and diseases: an update. Clin. Chim. Acta 2010, 411:1401-1411.
99. Khorasanizadeh S. The nucleosome: from genomic organization to genomic regulation. Cell 2004, 116:259-272.
100. Kim J., Guermah M., Mcginty R.K., Lee J.-S., Tang Z., Milne T.A., Shilatifard A., Muir T.W., Roeder R.G. RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 2009, 137:459-471.
101. Kleefstra T., Brunner H.G., Amiel J., Oudakker A.R., Nillesen W.M., Magee A., Geneviève D., Cormier-Daire V., Van Esch H., Fryns J.-P., Hamel B.C.J., Sistermans E.A., De Vries B.B.A., Van Bokhoven H. Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. Am. J. Hum. Genet. 2006, 79:370-377.
102. Kleefstra T., Kramer J.M., Neveling K., Willemsen M.H., Koemans T.S., Vissers L.E., Wissink-Lindhout W., Fenckova M., Van Den Akker W.M., Kasri N.N., Nillesen W.M., Prescott T., Clark R.D., Devriendt K., Van Reeuwijk J., De Brouwer A.P., Gilissen C., Zhou H., Brunner H.G., Veltman J.A., Schenck A., Van Bokhoven H. Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. Am. J. Hum. Genet. 2012, 91:73-82.
103. Klepper J. Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia 2008, 49(Suppl. 8):46-49.
104. Knauss J.L., Sun T. Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function. Neuroscience 2013, 235:200-214.
105. Kobow K., Blumcke I. The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?. Epilepsia 2011, 52(Suppl. 4):15-19.
106. Kobow K., Blumcke I. The emerging role of DNA methylation in epileptogenesis. Epilepsia 2012, 53(Suppl. 9):11-20.
107. Kobow K., Jeske I., Hildebrandt M., Hauke J., Hahnen E., Buslei R., Buchfelder M., Weigel D., Stefan H., Kasper B., Pauli E., Blumcke I. Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J. Neuropathol. Exp. Neurol. 2009, 68:356-364.
108. Kobow K., El-Osta A., Blumcke I. The methylation hypothesis of pharmacoresistance in epilepsy. Epilepsia 2013, 54(Suppl. 2):41-47.
109. Kobow K., Kaspi A., Harikrishnan K.N., Kiese K., Ziemann M., Khurana I., Fritzsche I., Hauke J., Hahnen E., Coras R., Muhlebner A., El-Osta A., Blumcke I. Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol. 2013, 126(5):741-756.
110. Kokaia M., Ernfors P., Kokaia Z., Elmer E., Jaenisch R., Lindvall O. Suppressed epileptogenesis in BDNF mutant mice. Exp. Neurol. 1995, 133:215-224.
111. Kovac S., Abramov A.Y., Walker M.C. Energy depletion in seizures: anaplerosis as a strategy for future therapies. Neuropharmacology 2013, 69:96-104.
112. Lachner M., Jenuwein T. The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 2002, 14:286-298.
113. Latham T., MacKay L., Sproul D., Karim M., Culley J., Harrison D.J., Hayward L., Langridge-Smith P., Gilbert N., Ramsahoye B.H. Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. Nucleic Acids Res. 2012, 40(11):4794-4803.
114. Lehnertz B., Ueda Y., Derijck A.A., Braunschweig U., Perez-Burgos L., Kubicek S., Chen T., Li E., Jenuwein T., Peters A.H. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 2003, 13:1192-1200.
115. Levenson J.M., Roth T.L., Lubin F.D., Miller C.A., Huang I.C., Desai P., Malone L.M., Sweatt J.D. Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J. Biol. Chem. 2006, 281:15763-15773.
116. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69:915-926.
117. Lipovich L., Dachet F., Cai J., Bagla S., Balan K., Jia H., Loeb J.A. Activity-dependent human brain coding/noncoding gene regulatory networks. Genetics 2012, 192:1133-1148.
118. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., Nery J.R., Lee L., Ye Z., Ngo Q.M., Edsall L., Antosiewicz-Bourget J., Stewart R., Ruotti V., Millar A.H., Thomson J.A., Ren B., Ecker J.R. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
119. Lister R., Mukamel E.A., Nery J.R., Urich M., Puddifoot C.A., Johnson N.D., Lucero J., Huang Y., Dwork A.J., Schultz M.D., Yu M., Tonti-Filippini J., Heyn H., Hu S., Wu J.C., Rao A., Esteller M., He C., Haghighi F.G., Sejnowski T.J., Behrens M.M., Ecker J.R. Global epigenomic reconfiguration during mammalian brain development. Science 2013, 341:1237905.
120. Liu M., Sheng Z., Cai L., Zhao K., Tian Y., Fei J. Neuronal conditional knockout of NRSF decreases vulnerability to seizures induced by pentylenetetrazol in mice. Acta Biochim. Biophys. Sin. 2012, 44:476-482.
121. Loenarz C., Schofield C.J. Expanding chemical biology of 2-oxoglutarate oxygenases. Nat. Chem. Biol. 2008, 4:152-156.
122. Lukasiuk K., Dabrowski M., Adach A., Pitkanen A. Epileptogenesis-related genes revisited. Prog. Brain Res. 2006, 158:223-241.
123. Luteijn M.J., Ketting R.F. PIWI-interacting RNAs: from generation to transgenerational epigenetics. Nat. Rev. Genet. 2013, 14:523-534.
124. Ma D.K., Marchetto M.C., Guo J.U., Ming G.L., Gage F.H., Song H. Epigenetic choreographers of neurogenesis in the adult mammalian brain. Nat. Neurosci. 2010, 13:1338-1344.
125. Machnes Z.M., Huang T.C., Chang P.K., Gill R., Reist N., Dezsi G., Ozturk E., Charron F., O'Brien T.J., Jones N.C., Mckinney R.A., Szyf M. DNA methylation mediates persistent epileptiform activity in vitro and in vivo. PLoS One 2013, 8:e76299.
126. Madrigano J., Baccarelli A., Mittleman M.A., Sparrow D., Vokonas P.S., Tarantini L., Schwartz J. Aging and epigenetics: longitudinal changes in gene-specific DNA methylation. Epigenetics 2012, 7:63-70.
127. Marfella C.G., Imbalzano A.N. The Chd family of chromatin remodelers. Mutat. Res. 2007, 618:30-40.
128. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., Rossetti C., Molteni M., Casalgrandi M., Manfredi A.A., Bianchi M.E., Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 2010, 16:413-419.
129. Martin C., Zhang Y. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 2005, 6:838-849.
130. Martinez-Garcia E., Licht J.D. Deregulation of H3K27 methylation in cancer. Nat. Genet. 2010, 42:100-101.
131. Martinowich K., Hattori D., Wu H., Fouse S., He F., Hu Y., Fan G., Sun Y.E. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003, 302:890-893.
132. Masino S.A., Rho J.M. Mechanisms of ketogenic diet action. Jasper's Basic Mechanisms of the Epilepsies (Contemporary Neurology Series) 2012, Oxford University Press, Oxford. fourth ed. J.L. Noebels, M. Avoli, M.A. Rogawski, R.W. Olsen, A.V. Delgado-Escueta (Eds.).
133. Maunakea A.K., Nagarajan R.P., Bilenky M., Ballinger T.J., D'Souza C., Fouse S.D., Johnson B.E., Hong C., Nielsen C., Zhao Y., Turecki G., Delaney A., Varhol R., Thiessen N., Shchors K., Heine V.M., Rowitch D.H., Xing X., Fiore C., Schillebeeckx M., Jones S.J., Haussler D., Marra M.A., Hirst M., Wang T., Costello J.F. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010, 466:253-257.
134. Medina C.F., Mazerolle C., Wang Y., Berube N.G., Coupland S., Gibbons R.J., Wallace V.A., Picketts D.J. Altered visual function and interneuron survival in Atrx knockout mice: inference for the human syndrome. Hum. Mol. Genet. 2009, 18:966-977.
135. Mellen M., Ayata P., Dewell S., Kriaucionis S., Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 2012, 151:1417-1430.
136. Meng L., Person R.E., Beaudet A.L. Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Hum. Mol. Genet. 2012, 21:3001-3012.
137. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10:155-159.
138. Metzger M.B., Pruneda J.N., Klevit R.E., Weissman A.M. RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochim. Biophys. Acta 2014, 1843:47-60.
139. Miller C.A., Sweatt J.D. Covalent modification of DNA regulates memory formation. Neuron 2007, 53:857-869.
140. Miller-Delaney S.F., Das S., Sano T., Jimenez-Mateos E.M., Bryan K., Buckley P.G., Stallings R.L., Henshall D.C. Differential DNA methylation patterns define status epilepticus and epileptic tolerance. J. Neurosci. 2012, 32:1577-1588.
141. Minkovsky A., Patel S., Plath K. Concise review: pluripotency and the transcriptional inactivation of the female mammalian X chromosome. Stem Cells 2012, 30:48-54.
142. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003, 425:962-967.
143. Muratani M., Tansey W.P. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 2003, 4:192-201.
144. Nelson E.D., Kavalali E.T., Monteggia L.M. Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J. Neurosci. 2008, 28:395-406.
145. Numata S., Ye T., Hyde T.M., Guitart-Navarro X., Tao R., Wininger M., Colantuoni C., Weinberger D.R., Kleinman J.E., Lipska B.K. DNA methylation signatures in development and aging of the human prefrontal cortex. Am. J. Hum. Genet. 2012, 90:260-272.
146. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
147. Olde Loohuis N.F., Kos A., Martens G.J., Van Bokhoven H., Nadif Kasri N., Aschrafi A. MicroRNA networks direct neuronal development and plasticity. Cell. Mol. Life Sci. 2012, 69:89-102.
148. Ono H., Sakamoto A., Mizoguchi N., Sakura N. Methylenetetrahydrofolate reductase 677C>T mutation and epilepsy. J. Inherit. Metab. Dis. 2000, 23:525-526.
149. Park S.Y., Kim J.B., Han Y.-M. REST is a key regulator in brain-specific homeobox gene expression during neuronal differentiation. J. Neurochem. 2007, 103:2565-2574.
150. Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic. Biol. Med. 2004, 37:1951-1962.
151. Peleg S., Sananbenesi F., Zovoilis A., Burkhardt S., Bahari-Javan S., Agis-Balboa R.C., Cota P., Wittnam J.L., Gogol-Doering A., Opitz L., Salinas-Riester G., Dettenhofer M., Kang H., Farinelli L., Chen W., Fischer A. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010, 328:753-756.
152. Pellegrini-Giampietro D.E., Gorter J.A., Bennett M.V., Zukin R.S. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci. 1997, 20:464-470.
153. Peng J., Omran A., Ashhab M.U., Kong H., Gan N., He F., Yin F. Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy. J. Mol. Neurosci. 2013, 50:291-297.
154. Petronis A. Human morbid genetics revisited: relevance of epigenetics. Trends Genet. 2001, 17:142-146.
155. Picketts D.J., Higgs D.R., Bachoo S., Blake D.J., Quarrell O.W., Gibbons R.J. ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Hum. Mol. Genet. 1996, 5:1899-1907.
156. Plummer R., Vidal L., Griffin M., Lesley M., De Bono J., Coulthard S., Sludden J., Siu L.L., Chen E.X., Oza A.M., Reid G.K., McLeod A.R., Besterman J.M., Lee C., Judson I., Calvert H., Boddy A.V. Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors. Clin. Cancer Res. 2009, 15:3177-3183.
157. Poduri A., Lowenstein D. Epilepsy genetics-past, present, and future. Curr. Opin. Genet. Dev. 2011, 21:325-332.
158. Poeta L., Fusco F., Drongitis D., Shoubridge C., Manganelli G., Filosa S., Paciolla M., Courtney M., Collombat P., Lioi M.B., Gecz J., Ursini M.V., Miano M.G. A regulatory path associated with X-linked intellectual disability and epilepsy links KDM5C to the polyalanine expansions in ARX. Am. J. Hum. Genet. 2013, 92:114-125.
159. Prins M.L. Cerebral metabolic adaptation and ketone metabolism after brain injury. J. Cereb. Blood Flow Metab. 2008, 28:1-16.
160. Qureshi I.A., Mehler M.F. Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol. Dis. 2010, 39:53-60.
161. Qureshi I.A., Mehler M.F. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat. Rev. Neurosci. 2012, 13:528-541.
162. Rajan I., Savelieva K.V., Ye G.L., Wang C.Y., Malbari M.M., Friddle C., Lanthorn T.H., Zhang W. Loss of the putative catalytic domain of HDAC4 leads to reduced thermal nociception and seizures while allowing normal bone development. PLoS One 2009, 4:e6612.
163. Rakhade S.N., Jensen F.E. Epileptogenesis in the immature brain: emerging mechanisms. Nat. Rev. Neurol. 2009, 5:380-391.
164. Rando O.J. Combinatorial complexity in chromatin structure and function: revisiting the histone code. Curr. Opin. Genet. Dev. 2012, 22:148-155.
165. Razin A., Riggs A.D. DNA methylation and gene function. Science 1980, 210:604-610.
166. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007, 447:425-432.
167. Rinn J.L., Chang H.Y. Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 2012, 81:145-166.
168. Ronan J.L., Wu W., Crabtree G.R. From neural development to cognition: unexpected roles for chromatin. Nat. Rev. Genet. 2013, 14:347-359.
169. Rudenko A., Dawlaty Meelad M., Seo J., Cheng Albert W., Meng J., Le T., Faull Kym F., Jaenisch R., Tsai L.-H. Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 2013, 79:1109-1122.
170. Ryley Parrish R., Albertson A.J., Buckingham S.C., Hablitz J.J., Mascia K.L., Davis Haselden W., Lubin F.D. Status epilepticus triggers early and late alterations in brain-derived neurotrophic factor and NMDA glutamate receptor Grin2b DNA methylation levels in the hippocampus. Neuroscience 2013, 248C:602-619.
171. Saharan S., Jhaveri D.J., Bartlett P.F. SIRT1 regulates the neurogenic potential of neural precursors in the adult subventricular zone and hippocampus. J. Neurosci. Res. 2013, 91:642-659.
172. Sanchez R.M., Koh S., Rio C., Wang C., Lamperti E.D., Sharma D., Corfas G., Jensen F.E. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J. Neurosci. 2001, 21:8154-8163.
173. Sapio M.R., Salzmann A., Vessaz M., Crespel A., Lyons P.J., Malafosse A., Fricker L.D. Naturally occurring carboxypeptidase A6 mutations: effect on enzyme function and association with epilepsy. J. Biol. Chem. 2012, 287:42900-42909.
174. Sati S., Tanwar V.S., Kumar K.A., Patowary A., Jain V., Ghosh S., Ahmad S., Singh M., Reddy S.U., Chandak G.R., Raghunath M., Sivasubbu S., Chakraborty K., Scaria V., Sengupta S. High resolution methylome map of rat indicates role of intragenic DNA methylation in identification of coding region. PLoS One 2012, 7:e31621.
175. Scheiffele P., Beg A.A. Neuroscience: Angelman syndrome connections. Nature 2010, 468:907-908.
176. Schratt G.M., Tuebing F., Nigh E.A., Kane C.G., Sabatini M.E., Kiebler M., Greenberg M.E. A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439:283-289.
177. Shimazu T., Hirschey M.D., Newman J., He W., Shirakawa K., Le Moan N., Grueter C.A., Lim H., Saunders L.R., Stevens R.D., Newgard C.B., Farese R.V., De Cabo R., Ulrich S., Akassoglou K., Verdin E. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 2013, 339:211-214.
178. Shoubridge C., Fullston T., Gecz J. ARX spectrum disorders: making inroads into the molecular pathology. Hum. Mutat. 2010, 31:889-900.
179. Smith Z.D., Meissner A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 2013, 14:204-220.
180. Sng J.C., Taniura H., Yoneda Y. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation. Neurosci. Lett. 2005, 386:150-155.
181. Sng J.C., Taniura H., Yoneda Y. Histone modifications in kainate-induced status epilepticus. Eur. J. Neurosci. 2006, 23:1269-1282.
182. Suls A., Jaehn J.A., Kecskes A., Weber Y., Weckhuysen S., Craiu D.C., Siekierska A., Djemie T., Afrikanova T., Gormley P., Von Spiczak S., Kluger G., Iliescu C.M., Talvik T., Talvik I., Meral C., Caglayan H.S., Giraldez B.G., Serratosa J., Lemke J.R., Hoffman-Zacharska D., Szczepanik E., Barisic N., Komarek V., Hjalgrim H., Moller R.S., Linnankivi T., Dimova P., Striano P., Zara F., Marini C., Guerrini R., Depienne C., Baulac S., Kuhlenbaumer G., Crawford A.D., Lehesjoki A.E., De Witte P.A., Palotie A., Lerche H., Esguerra C.V., De Jonghe P., Helbig I. De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. Am. J. Hum. Genet. 2013, 93:967-975.
183. Sultan F.A., Wang J., Tront J., Liebermann D.A., Sweatt J.D. Genetic deletion of Gadd45b, a regulator of active DNA demethylation, enhances long-term memory and synaptic plasticity. J. Neurosci. 2012, 32:17059-17066.
184. Sun A.X., Crabtree G.R., Yoo A.S. MicroRNAs: regulators of neuronal fate. Curr. Opin. Cell Biol. 2013, 25:215-221.
185. Szulwach K.E., Li X., Li Y., Song C.X., Wu H., Dai Q., Irier H., Upadhyay A.K., Gearing M., Levey A.I., Vasanthakumar A., Godley L.A., Chang Q., Cheng X., He C., Jin P. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci. 2011, 14:1607-1616.
186. Takahashi K., Sugi Y., Hosono A., Kaminogawa S. Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J. Immunol. 2009, 183:6522-6529.
187. Tardat M., Murr R., Herceg Z., Sardet C., Julien E. PR-Set7-dependent lysine methylation ensures genome replication and stability through S phase. J. Cell Biol. 2007, 179:1413-1426.
188. Tsankova N.M., Kumar A., Nestler E.J. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J. Neurosci. 2004, 24:5603-5610.
189. Tsurusaki Y., Okamoto N., Ohashi H., Kosho T., Imai Y., Hibi-Ko Y., Kaname T., Naritomi K., Kawame H., Wakui K., Fukushima Y., Homma T., Kato M., Hiraki Y., Yamagata T., Yano S., Mizuno S., Sakazume S., Ishii T., Nagai T., Shiina M., Ogata K., Ohta T., Niikawa N., Miyatake S., Okada I., Mizuguchi T., Doi H., Saitsu H., Miyake N., Matsumoto N. Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat. Genet. 2012, 44:376-378.
190. Turkmen S., Gillessen-Kaesbach G., Meinecke P., Albrecht B., Neumann L.M., Hesse V., Palanduz S., Balg S., Majewski F., Fuchs S., Zschieschang P., Greiwe M., Mennicke K., Kreuz F.R., Dehmel H.J., Rodeck B., Kunze J., Tinschert S., Mundlos S., Horn D. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes. Eur. J. Hum. Genet. 2003, 11:858-865.
191. Van Der Lugt N.M., Domen J., Linders K., Van Roon M., Robanus-Maandag E., Te Riele H., Vander Valk M., Deschamps J., Sofroniew M., Vanlohuizen M., et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 1994, 8:757-769.
192. Varley K.E., Gertz J., Bowling K.M., Parker S.L., Reddy T.E., Pauli-Behn F., Cross M.K., Williams B.A., Stamatoyannopoulos J.A., Crawford G.E., Absher D.M., Wold B.J., Myers R.M. Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res. 2013, 23:555-567.
193. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
194. Vezzani A., Baram T.Z. New roles for interleukin-1 beta in the mechanisms of epilepsy. Epilepsy Curr. 2007, 7:45-50.
195. Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., Van Eynde A., Bernard D., Vanderwinden J.M., Bollen M., Esteller M., Di Croce L., De Launoit Y., Fuks F. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006, 439:871-874.
196. Walczak A., Szczepankiewicz A.A., Ruszczycki B., Magalska A., Zamlynska K., Dzwonek J., Wilczek E., Zybura-Broda K., Rylski M., Malinowska M., Dabrowski M., Szczepinska T., Pawlowski K., Pyskaty M., Wlodarczyk J., Szczerbal I., Switonski M., Cremer M., Wilczynski G.M. Novel higher-order epigenetic regulation of the Bdnf gene upon seizures. J. Neurosci. 2013, 33:2507-2511.
197. Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S., Zhang Y. Role of histone H2A ubiquitination in Polycomb silencing. Nature 2004, 431:873-878.
198. Wang Z., Zang C., Rosenfeld J.A., Schones D.E., Barski A., Cuddapah S., Cui K., Roh T.-Y., Peng W., Zhang M.Q., Zhao K. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat. Genet. 2008, 40:897-903.
199. Wang X., Song X., Glass C.K., Rosenfeld M.G. The long arm of long noncoding RNAs: roles as sensors regulating gene transcriptional programs. Cold Spring Harb. Perspect. Biol. 2011, 3:a003756.
200. Wang T., Pan Q., Lin L., Szulwach K.E., Song C.X., He C., Wu H., Warren S.T., Jin P., Duan R., Li X. Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum. Hum. Mol. Genet. 2012, 21:5500-5510.
201. Williams S.R., Mullegama S.V., Rosenfeld J.A., Dagli A.I., Hatchwell E., Allen W.P., Williams C.A., Elsea S.H. Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures. Eur. J. Hum. Genet. 2010, 18:436-441.
202. Williams-Karnesky R.L., Sandau U.S., Lusardi T.A., Lytle N.K., Farrell J.M., Pritchard E.M., Kaplan D.L., Boison D. Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J. Clin. Invest. 2013, 123:3552-3563.
203. Wu S.C., Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat. Rev. Mol. Cell Biol. 2010, 11:607-620.
204. Wu X., Gong Y., Yue J., Qiang B., Yuan J., Peng X. Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing. Nucleic Acids Res. 2008, 36:3590-3599.
205. Xu B., Michalski B., Racine R.J., Fahnestock M. The effects of brain-derived neurotrophic factor (BDNF) administration on kindling induction, Trk expression and seizure-related morphological changes. Neuroscience 2004, 126:521-531.
206. Yoo A.S., Sun A.X., Li L., Shcheglovitov A., Portmann T., Li Y., Lee-Messer C., Dolmetsch R.E., Tsien R.W., Crabtree G.R. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 2011, 476:228-231.
207. Zhang Y. Transcriptional regulation by histone ubiquitination and deubiquitination. Genes Dev. 2003, 17:2733-2740.
208. Zhu Q., Wang L., Zhang Y., Zhao F.H., Luo J., Xiao Z., Chen G.J., Wang X.F. Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy. J. Mol. Neurosci. 2011, 46:420-426.
209. Ziller M.J., Muller F., Liao J., Zhang Y., Gu H., Bock C., Boyle P., Epstein C.B., Bernstein B.E., Lengauer T., Gnirke A., Meissner A. Genomic distribution and inter-sample variation of non-CpG methylation across human cell types. PLoS Genet. 2011, 7:e1002389.